Activation of TGF‐β within cultured hepatocytes and in liver injury leads to intracrine signaling with expression of connective tissue growth factor
Open Access
- 2 December 2008
- journal article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 12 (6b) , 2717-2730
- https://doi.org/10.1111/j.1582-4934.2008.00260.x
Abstract
Recently, synthesis and secretion of connective tissue growth factor (CTGF)/CYR61/CTGF/NOV-family member 2 (CCN2) in cultures of hepatocytes were shown, which are sensitively up-regulated by exogenous TGF-β. In this study TGF-β-dependent CTGF/CCN2 expression in hepatocytes cultured under completely TGF-β-free conditions was analysed by Western-blots, metabolic labelling, and CTGF-reporter gene assays. In alkaline phosphatase monoclonal anti-alkaline phosphatase complex (APAAP)-staining of cultured hepatocytes it was demonstrated that latent TGF-β within the hepatocytes becomes rapidly detectable during culture indicating an intracellular demasking of the mature TGF-β antigen. Subsequent signaling to theCTGF/CCN2 promoter occurs via p-Smad2, whereas p-Smad3 does not seem to be involved. Cycloheximide did not abolish the rapid immunocytochemical appearance of mature TGF-β, but calpain inhibitors partially suppressed intracellular TGF-β activation and subsequently CTGF up-regulation. Calpain treatment had the reverse effect. None of the inhibitors of extracellular TGF-β signalling was effective in the reduction of spontaneous CTGF synthesis, but intracellularly acting Alk 4-/Alk 5-specific inhibitor SB-431542 was able to diminish CTGF expression. The assumption that latent intracellular TGF-β is activated by calpains during culture-induced stress or injurious conditions in the liver in vivo was further validated by a direct effect of calpains on the activation of recombinant latent TGF-β. In conclusion, these data are the first to suggest the possibility of intracrine TGF-β signalling due to calpain-dependent intracellular proteolytic activation leading to transcriptional activation of CTGF/CCN2 as a TGF-β-sensitive reporter gene. This mechanism might be deleterious for keeping long-term hepatocyte cultures due to TGF-β-induced apoptosis and, further, might be of relevance for induction of apoptosis or epithelial-mesenchymal transition of hepatocytes in injured liver.Keywords
This publication has 69 references indexed in Scilit:
- Differential effects of TGF-β on connective tissue growth factor (CTGF/CCN2) expression in hepatic stellate cells and hepatocytesJournal of Hepatology, 2007
- Emerging insights into Transforming growth factor Smad signal in hepatic fibrogenesisGut, 2007
- TGF‐β control of cell proliferationJournal of Cellular Biochemistry, 2005
- TAp63α induces apoptosis by activating signaling via death receptors and mitochondriaThe EMBO Journal, 2005
- New insights into TGF-β–Smad signallingPublished by Elsevier ,2004
- Intracellular Cyclic Nucleotide Analogues Inhibit in vitro Mitogenesis and Activation of Fibroblasts Derived from Obstructed Rat KidneysNephron Experimental Nephrology, 2004
- TGF-β-mediated hepatocellular apoptosis by rat and human hepatoma cells and primary rat hepatocytesJournal of Hepatology, 1997
- Attenuation of TGF-β-Induced Apoptosis in Primary Cultures of Hepatocytes by Calpain InhibitorsBiochemical and Biophysical Research Communications, 1997
- Variation of immunocytochemical expression of transforming growth factor (TGF)-β in hepatocytes in culture and liver slicesCell and tissue research, 1996
- Preventive Effects of Acute Inflammation on Liver Cell Necrosis and Inhibition of Heparan Sulphate Synthesis in Hepatocytescclm, 1986